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Abstract 
Background: Malaria caused by the parasite Plasmodium falciparum is an acute disease which kills an estimated 
863,000 people per year according to the WHO report of 2009. The fight against malaria is faced with the occurrence 
of widespread resistance of P.  falciparum. The search for plant-derived antimalarial drugs has great importance in this 
regard. Thus this study evaluates the toxicity and antimalarial activity of extracts of Clerodendrum myricoides, 
Dodonia angustifolia and Aloe debrana. 
Method: Acute and sub acute toxicity studies of the extracts were carried out by giving up to 3000mg/kg to non-
infected mice. Weight loss, change in general behavior and mortality were used as indicators of toxicity. Doses of 200, 
400 & 600mg/kg/day of each extract of C.myricoides, D. dodonia and A.debrana were given orally to Plasmodium 
berghei infected mice following the four-day suppressive test procedure.  
Results: None of the extracts caused symptoms of toxicity at the given doses. Each extract showed variable level of 
parasitaemia suppression in dose related manner. Methanol extract of C. myricoides leaves exerted 82.50% 
suppression at the dose of 600mg/kg. The methanol extract of the root of D.  angustifolia showed the highest (84.52%) 
suppression of parasitaemia at the dose of 600mg/kg. Furthermore, methanol extract of A. debrana induced 73.95% 
suppression, whereas its water extract exerted 54.36% suppression of parasitaemia.  
Conclusion: Crude extracts of C. myricoides, D. angustifolia and A.debrana caused strong activities against P. berghei 
indicating that they contain some chemical constituents that possibly lead to antimalarial drug development.  [Ethiop. J. 
Health Dev. 2010; 24(1):25-29] 
 
Introduction 
Malaria remains one of the world’s leading health 
problems with about 863,000 deaths annually (1). Most 
of these deaths are caused by Plasmodium falciparum, 
one of the four species of malaria causing parasites in 
humans. The burden of mortality in sub-Saharan Africa is 
accounted for 89% of the deaths where 5% of children 
die from the disease before reaching 5 years of age. One 
of the factors that contributed to this grim picture of 
malaria is the emergence and wide spread of P. 
falciparum resistance to the standard antimalarial drugs, 
which necessitates a continuous effort to search for new 
drugs (2).  
 
In malaria endemic countries traditional medicinal plants 
are frequently used to treat malaria (3). The analysis of 
traditional medicines that are employed for the treatment 
of malaria represents a potential for discovery of lead 
molecules for development of antimalarial drugs (4). For 
example, quinine derivatives were modeled on the 
quinine molecule, found from the bark of Cinchona tree 
of South America (5). The recently formulated potent and 
effective artemisinin derivatives are isolated from 
Artemisia annua, a plant used for thousands of years to 
treat malaria by the Chinese people (6). The success in 
isolation of artemisinin has inspired many researchers to 
look for new antimalarial drugs from plants that are being 
used to treat malaria in traditional health care systems.  
 
In Ethiopia it is estimated that about 80% of the 
Ethiopian population is still dependent on traditional 
medicine, which essentially involves the use of plants (7). 
Despite their wide use in the traditional health care, the 
work that has been done to evaluate the safety and 
efficacy of Ethiopian traditional medicinal plants is not 
extensive. Previous studies have shown the antimalarial 
activities of Vernonia amygdalina and Withania 
somnifera in vitro against P. falciparum (8) and activities 
of these plants against P. berghei in mice (9). Similarly, 
Dodonia angustifolia was reported to have activity 
against P. falciparum in vitro (10). Due to the 
aforementioned facts and the claimed use of these plants 
for malaria control, the objective of the this study is to 
test the antimalarial activities of Clerodendrum  
myricoides, Dodonia angustifolia and Aloe debrana in 
vivo system in mice. 
 
Methods 
Plant materials and extraction: Leaves of C. myricoides, 
D. angustifolia and A. debrana were collected from three 
different localities namely Wolisso (114 Km Southwest 
of Addis Ababa), Wondogenet (about 270 Km South of 
Addis Ababa) and Addis Ababa, during the months of 
November and December, 2006. The identification and 
authentication of the plant specimens was done at The 
National Herbarium, Department of Biology of the Addis 
Ababa University. These species were previously 
collected and voucher specimens deposited. The plant 
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samples were air-dried at room temperature under shade, 
and ground into powder using an electric mill.  
 
The crude extracts were prepared by cold maceration 
technique (11). Aqueous and/or methanol (98%) extract 
of each specimen was prepared. The extraction was done 
by refluxing 50 g of plant material in 300 ml of methanol 
(98%) or distilled water and placing the mixture on 
orbital shaker (at 160rpm) for 24 hrs. The mixture was 
first filtered using cotton and then the filtrate was passed 
through Whatman filter paper (No.3, 15cm size with 
retention down to 0.1µm in liquids). The methanol (98%) 
extracts were concentrated in a rotary evaporator (Buchi 
type TRE121, Switzerland) at a temperature of 450C; 
whereas the water extract freeze-dried using centrifugal 
freeze drier (model 5 PS, England). All the extracts were 
stored in screw cap vials at -20oc until they were applied 
in the experiment. The water and methanol (98%) 
extracts were dissolved in 10ml of distilled water and 
Tween 80 (3 %) respectively for the experiment.  
 
Acute toxicity study: The crude extracts were evaluated 
for their toxicity in P. berghei non-infected male Swiss 
albino mice aged six to eight weeks and weighing 27-34g. 
For the test of each extract, 15 mice were randomly 
divided into three groups of five animals per cage. Before 
oral administration of a single dose of each extract, the 
mice were fasted for one to two hrs (12, 13).  Then, the 
mice in Group 1 were given orally 0.2ml of methanol 
and/or water extracts of C. myricoides and A. debrana 
leaves and methanol extract of D. angustifolia roots at a 
single dose of 3,000 mg/kg, and the mice in Group 2 
were given 0.2ml of each extract at dose of 1500mg/kg of 
body weight. The mice in control group received 0.5ml 
of respective vehicle of each extract (dH2O or 3% Tween 
80). Then, the mice were observed continuously for one 
hr after the treatment; intermittently for four hrs, and 
thereafter over a period of 24 hrs (14). The mice were 
observed for gross behavioral changes such as feeding, 
hair erection, lacrimation, mortality and other signs of 
toxicity manifestation (15).  
 
The parasite and infection: For in vivo antimalarial 
assays of plant extracts, Chloroquine (CQ) sensitive 
strain of P. berghei maintained at the animal house of the 
Biology Department, Addis Ababa University was used. 
The parasites were maintained by serial passage of blood 
from infected mice to non-infected ones on weekly basis. 
 
To infect the mice, blood sample was collected from 
auxiliary vessels of a donor mouse with a rising 
parasitaemia of about 30-37%. Then, the blood was 
diluted in normal saline so that each 0.2ml contained 
approximately 106 infected red blood cells. Each animal 
received inoculums of about 106 parasites via 
intraperitoneal route (IP). The inoculated mice were then 
randomized into five mice per cage and maintained in the 
animal house on a commercial diet and water ad libitum. 
Antimalarial activity of plant extracts: In screening of 
the plant extracts, the standard four-day suppressive 
method was used (16). Male Swiss albino mice weighing 
27-32g were infected with106 P. berghei and randomly 
divided into five groups of five mice per cage. The 
infected mice were randomly divided into three test 
groups and two control groups (each for CQ as a standard 
drug and dH2O or 3% Tween 80 as a negative control). 
The test extracts were prepared in three different doses 
(200mg/kg, 400mg/kg, and 600mg/kg of body weight) 
and CQ at 25mg/kg in a volume of 0.2ml and vehicles at 
0.5ml/mouse. Each extract was administered as a single 
dose per day. All the extracts and the drug were given 
through intragastric route by using standard intragastric 
tube to insure safe ingestion of the extracts and the drug. 
Treatment was started after 3 hrs of infection on day 0 
and was then continued daily for four days (i.e. from day 
0 to day 3). On the fifth day (D4) blood sample was 
collected from tail snip of each mouse. Thin smears were 
prepared and stained with 10% Geimsa solution.  Then, 
each stained slide was examined under the microscope 
with an oil immersion objective of 100x magnification 
power to evaluate the percent suppression of each extract 
with respect to the control groups. The experiments were 
done by one of the authors, the parasite count was 
performed by an experienced technician (double blinded) 
and the animal keeper looked after the experimental mice 
during the course of the study. 
 
Data analysis: Results of the study were expressed as 
mean ± standard error of mean (M ± SEM). Comparison 
of parasitaemia and statistical significance was 
determined by one-way ANOVA (repeated measure of 
analysis of variance) and post hoc Scheffe’s test using 
SPSS for window (Version 13.0) statistical package. All 
data were analyzed at a 95% confidence interval (P = 
0.05). Percent parasitaemia and percent suppression were 
also calculated (17, 18). 
  
 Results 
The acute toxicity study indicated that none of the four 
extracts caused mortality of mice within 24 hrs up to 
3000mg/kg. Gross physical and behavioral observation of 
the experimental mice also revealed no visible signs of 
acute toxicity like lacrimation, hair erection, and 
reduction in their motor and feeding activities. They were 
physically active. 
 
The methanol extract of C.myricoides showed 54% 
suppression of parasitaemia at the dose of 200mg/kg 
(Table 1). The highest suppression of parasitaemia was 
observed at the dose of 600mg/kg body weight of mice. 
Percentage suppression was observed to increase as 
extract concentration increased. After four days treatment 
with the different extract doses, the mean parasitaemia of 
the test groups ranged from 2.7 ± 0.14% to 7.18 ± 0.32% 
while the corresponding value of the negative control 
group being 15.62 ± 0.68%. The mice treated with CQ 
were completely free from the parasites on day four. 
 
 
Table 1:  Activity of methanol extracts of C. myricoides leaves and D. angustifolia against P. berghei in mice 
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Dose (mg/kg/day) Antimalarial activity Extract 
 % Parasitemia ±SEM % Suppression 
NC 15.62±0.68a 00.00a 
200 7.18±0.32b 54.14b 
400 5.32±0.13c 65.95c 
C. myricoides 
600 2.74±0.14d 82.50d 
NC 11.92±0.55a 00.00a 
200 5.37±0.28b 57.74b 
400 3.38±0.05c 71.51c 
D. angustifolia 
600 1.84±0.05d 84.52d 
Values are Mean ±SEM; n=5, NC: Negative control (0.5ml vehicle); a,b,c,d = Values in the same column followed by the 
same letter do not differ significantly (P>0.05) 
 
Significant reduction of parasitaemia (P < 0.05) was also 
observed in all groups of mice treated with methanol 
extract of the roots of D. angustifolia compared to the 
negative control. The percent parasitaemia of the mice 
treated with 200mg/kg of the extract was 5.37 ± 0.28 and 
the mice that received 600mg/kg was 1.84 ± 0.06. 
Whereas, the parasitaemia of the control mice (treated 
with dH2O) was 11.92 ± 0.95. Its parasitaemia 
suppression ranged from 57.74% to 84.52%. The highest 
suppression was induced in the group treated with the 
highest dose (600mg/kg).  
 
Methanol extract of A. debrana leaves induced 73.95% 
parasitaemia suppression at the highest dose (600mg/kg). 
The parasitaemia of the mice treated with the extract 
ranged from 2.89 ± 0.04 to 11.15 ± 0.52. Reduction of 
the parasitaemia was dose dependent (Table 2). 
 
Table 2:  Activity of methanol and water extracts of leaves of A.debrana against P. berghei in mice 
Dose (mg/kg/day) Antimalarial activity Extract 
 % Parasitemia ±SEM % Suppresion 
NC 11.15±0.52a 00.00a 
200 7.78±0.27b 30.21b 
400 6.22±0.17c 44.15c 
A. debrana methanol extract 
600 2.89±0.04d 73.95d 
NC 14.16±0.34a 00.00a 
200 10.82±0.14b 23.53b 
400 9.45±0.24c 33.22c 
A. debrana water extract 
600 0.46±0.11d 54.36d 
Values are Mean ±SEM; n=5, NC: Negative control (0.5ml vehicle); a,b,c,d = Values in the same column followed by the 
same letter do not differ significantly (P>0.05) 
 
The aqueous extract of the leaves of A. debrana, mean 
parasitaemia in P. berghei infected mice ranged from 
6.46 ± 0.11 to 10.82 ± 0.14, whereas the corresponding 
figure in the control group (treated with 0.2ml dH2O) was 
14.16 ± 0.34. The extract induced statistically significant 
inhibition of parasitaemia in all the doses tested 
compared to the negative control (P < 0.05). Treatment 
with this extract at 600mg/kg exerted 54.36% parasite 
suppression.  
 
The mice treated with CQ were completely free from the 
parasites on day four in all the experiments using the 
methanol extracts of C. myricoides leaves, D. 
angustifolia roots and methanol and water extract of the 
leaves of A Debrana. 
 
Discussion 
Methanol extracts of the leaves of C. myricoides, D. 
angustifolia, A. debrana and water extract of the leaves 
of A. debrana were tested for their toxicity against Swiss 
albino mice and for their antimalarial activity against P. 
berghei in mice. None of the test mouse died or showed 
signs of acute toxicity within 24 hours of treatment with 
the test extracts. According to CDER (14), acute toxicity 
is a toxicity produced by a pharmaceutical when 
administered in one or more doses within a period not 
exceeding 24 hours. Accordingly, the extracts were non-
toxic to test mice, as they did not show signs of acute 
toxicity within 24 hours at the doses of 1500mg/kg and 
3000mg/kg. Changes in general behaviors, variations in 
body weight and mortality are critical for the evaluation 
of the effect of a compound on test animals, since such 
changes are often the first signs of toxicity (19).  
Similarly, sub acute toxicity study of the extracts 
revealed no signs of toxicity manifestations within 14 
days at the dose levels tested. This shows that, all the test 
extracts were non-toxic to the test mice.  
 
Methanol extract of the leaves of C. myricoides 
significantly (p< 0.05) inhibited parasitaemia of P. 
berghei in mice. This parasitaemia suppression effect of 
the extract may be attributed to the presence of alkaloids 
that have been reported to be the major constituents of 
the Clerodendrum species (20). However, the active 
compound(s) known to give the observed activity need to 
be identified and quantified. The leaves of Clerodendrum 
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species were reported to cause 90.13%  in vivo 
suppression (21) and strong in vitro activity with IC50 
9.51-10.56µg/ml in P. falciparum (22). In addition, it is 
reported to have strong in vitro activity with IC50 of less 
than 30µg/ml in combination with CQ against both CQ 
sensitive and CQ resistant P. falciparum. Even though 
the rodent malaria model, P.berghei, is not exactly 
similar to that of the human Plasmodium parasites, it is 
the first step to screen most of the in vivo antimalarial 
activities of new molecules and new therapeutics (23).  
Therefore, this study, together with the aforementioned 
reports, shows that the plant may serve as a potential 
source of different antiplasmodial compounds. 
 
The result obtained from the methanol extract of root of 
D. angustifolia was more homogeneous, and all treated 
groups with the extract showed a significant reduction in 
parasitaemia compared to the negative control. The 
suppression activity of this extract was observed to be 
dose dependent, increasing with increase in the 
concentration of the extract. Previously in vitro activity 
of D.angustifolia extract of seeds of the plant against P. 
falciparum was reported (10); suggesting that the plant 
may possess antimalarial compounds. 
 
Different studies indicated that D. angustifolia has 
several secondary metabolites like quinines, saponins, 
flavonoides, alkaloids, terpenoids, diterpenoids, and 
essential oils (24, 25). Although the active compound is 
not yet identified, the antiplasmodial activity observed in 
this study could probably have resulted from a single or 
combined effect of these compounds. The plant part is 
reported to be a remedy for stomach disturbances and 
diarrhea in humans (26); cestodes infection (27) and 
malaria (28, 29) in humans. The result of this study is 
therefore, in agreement with the traditional use of this 
plant for antimalarial therapy.  
 
In this study, both the methanol and water extracts of A. 
debrana showed considerable antiplasmodial properties. 
The suppression activities of both extracts were increased 
with increase in the concentration of the extracts. The 
parasitaemia suppression effect of A. debrana extracts 
may be explained in light of the presence of high 
concentration of anthraquinones and other quinoid 
compounds that are the characteristic constituent of the 
genus Aloe (30). Comparatively the water extract of the 
leaves of A. debrana showed lower antimalarial activities 
than its methanol counterpart. This might indicate that 
the active compounds for the observed antimalarial 
activities of the two extracts are different. Hence, 
bioactivity guided isolation of the active ingredient that 
exhibit this activity is important.  
 
In conclusion, crude extracts of C. myricoides, D. 
angustifolia and A. debrana caused strong activities 
against P. berghei indicating that these plants contain 
some lead antiplasmodial compounds. However, the 
crude extracts should be further fractionated and tested 
for their activity against P. falciparum and P. vivax in 
order to consider them as potential sources for 
antimalarial drug development for human malaria. 
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